HOME >> BIOLOGY >> NEWS
Mathematical rule said to be widely and wrongly used to forecast future beach erosion

DURHAM, N.C. -- A decades-old mathematical model is being inappropriately used in at least 26 nations to make potentially costly predictions about how shorelines will retreat in response to rising sea levels, two coastal scientists contended in the Friday, March 19, 2004, issue of the research journal Science.

"Models can be a hazard to society, and this is certainly an example of such," wrote Orrin Pilkey of Duke University's Nicholas School of the Environment and Earth Sciences, and J. Andrew Cooper of the Coastal Research Group at the University of Ulster in Northern Ireland, in a Perspectives commentary.

The mathematical equation, called the Bruun rule, "is a 'one model fits all' approach unsuitable in a highly complex natural environment with large spatial variations in shoreline retreat," the two authors added. "Even under ideal conditions ... the rule has never been credibly shown to provide accurate predictions."

Pilkey, a retired geology professor who still directs Duke's Program for the Study of Developed Shorelines, said in an interview that the rule was developed in the 1960s by Per Bruun, a Danish civil engineer who was long active in Florida beach preservation projects.

According to Pilkey, the Bruun rule stipulates that it is the slope of the "shoreface" -- the broad front of a beach extending down into the water to a depth of about 10 yards -- that controls how and how quickly a beach "erodes," meaning how it retreats landward as sea level rises.

"There is no relationship between the shoreface slope and the rate of erosion," he said. "We know that each shoreline is different, and one model cannot possibly explain every shoreface. It's ludicrous. And yet it's being defended by a number of people."

Their commentary also said the Bruun rule is intended "to be deployed only under a limited range of environmental circumstances (such as uniform sandy shorefaces with no rock or mud outcrops). Unfort
'"/>

Contact: Monte Basgall
monte.basgall@duke.edu
919-681-8057
Duke University
18-Mar-2004


Page: 1 2 3

Related biology news :

1. Applied Mathematical Models in Human Physiology
2. Mathematical modeling predicts cellular communication
3. Mathematical models reveal molten and glassy states of RNA
4. Mathematical prediction of on-off switches in cell division proven
5. Mathematical model provides new tool to assess mail-borne spread of anthrax
6. Mathematical analysis could aid flu vaccine selection
7. New Mathematical Model Could Help Predict Health Of Offshore Areas Where Rivers Enter The Sea
8. Penn engineers develop fuel cell that uses liquid diesel, the first such device to run on a widely available fuel
9. Report: Proteins can be engineered as widely adaptable bioelectronic sensors
10. UF research suggests widely used models may under predict pollution
11. Ginkgo herbal supplements vary widely in content

Post Your Comments:
(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/26/2015)... -- The Granite Club, Canada,s ... today announced it has implemented a state-of-the-art access and ... members and staff, while restricting access to authorized users ... FST,s IMID Access system because it has the perfect ... staff, in addition to unparalleled security," said James ...
(Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 ... of Debiopharm Group ™ , a Swiss-based global ... unmet medical needs as well as companion ... the investigational compounds Debio 1143 (SMAC mimetic) and ... at the 2015 Annual meeting of the ...
(Date:4/16/2015)... Washington (PRWEB) April 16, 2015 ... Applied Cancer Science and Resolution Bioscience, Inc. today ... to co-develop a novel, blood-based, clinic ready, Next ... cancer (NSCLC). The collaboration is the first to ... RET, and ROS1 fusions in blinded plasma samples ...
Breaking Biology Technology:RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
Cached News: